146 related articles for article (PubMed ID: 14619463)
21. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
Mao G; Gao Z; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
23. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
Matsuzaki Y; Shibata K; Yoshioka M; Inoue M; Sekiya R; Onitsuka T; Iwamoto I; Koga Y
Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
[TBL] [Abstract][Full Text] [Related]
24. A new approach to the treatment of malignant effusion.
Li DJ; Wang YR; Tan XY; Wang HZ; Yao XD; Ba DN
Chin Med J (Engl); 1990 Dec; 103(12):998-1002. PubMed ID: 2127253
[TBL] [Abstract][Full Text] [Related]
25. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
Guo YS; Xing ZL
Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
[TBL] [Abstract][Full Text] [Related]
26. Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.
Chu H; Du F; Gong Z; Lian P; Wang Z; Li P; Hu B; Chi C; Chen J
Anticancer Res; 2017 Aug; 37(8):4587-4591. PubMed ID: 28739756
[TBL] [Abstract][Full Text] [Related]
27. Video-assisted management of malignant pleural effusion in breast carcinoma.
Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
29. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
[TBL] [Abstract][Full Text] [Related]
30. [Extrapleural pneumonectomy after hyperthermo-chemotherapy for the lung cancer patients with malignant pleural effusion].
Suzuki K; Funai K; Shundo Y; Asano K; Takamochi K; Asai K; Kazui T; Miura K
Kyobu Geka; 2004 Oct; 57(11):1023-7. PubMed ID: 15510815
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
32. Pleural effusion in breast cancer: influence upon clinical course and survival.
Singer TS; Sulkes A; Biran S
Chemioterapia; 1986 Feb; 5(1):66-9. PubMed ID: 3955787
[TBL] [Abstract][Full Text] [Related]
33. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.
Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762
[TBL] [Abstract][Full Text] [Related]
34. [Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer].
Saisho S; Saeki T; Takashima S; Aogi K; Ohsumi S
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2063-8. PubMed ID: 14712766
[TBL] [Abstract][Full Text] [Related]
35. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
37. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
38. [Negative pleural cytology after intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion].
Yagi T; Ueda K; Kaneda Y; Sakano H; Tanaka T; Matsuoka T; Sudo M; Hayashi M; Hamano K
Kyobu Geka; 2004 Feb; 57(2):107-10. PubMed ID: 14978902
[TBL] [Abstract][Full Text] [Related]
39. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer].
Gu LJ; Wang WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1023-6. PubMed ID: 16864104
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
Khammari A; Nguyen JM; Pandolfino MC; Quereux G; Brocard A; Bercegeay S; Cassidanius A; Lemarre P; Volteau C; Labarrière N; Jotereau F; Dréno B
Cancer Immunol Immunother; 2007 Nov; 56(11):1853-60. PubMed ID: 17549472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]